SUPERNUS PHARMACEUTICALS, INC. - 10-Q Filing
Supernus Pharmaceuticals reported Q2 financial results with revenue and operating expenses.
Tickers: $SUPN
Supernus Pharmaceuticals reported Q2 financial results with revenue and operating expenses.
Tickers: $SUPN